Pharmacoepidemiological Rationale for the Use of Antibacterial Drugs for the Treatment of Community-Acquired Pneumonia in Children of Different Ages

Moraxella Haemophilus influenzae Streptococcus pneumoniae

Authors

August 30, 2024

Downloads

Community-acquired pneumonia (CAP) is a common clinical problem faced by physicians worldwide. EP is an indicator of the consumption of antibacterial drugs (AP), since this disease constitutes the majority of antibiotic prescriptions for therapeutic patients in the hospital. Hospital spending on medicines (MD) is on average 20% of their budget, more than half of which is AP spending.